At Visakhapatnam
Divi's Laboratories has been informed by the USFDA that it will lift the Import Alert 99-32 imposed on the company's Unit-II at Visakhapatnam.The USFDA has issued an Import Alert under clauses 99-32 and 66-40 in March of 2017 and a warning letter in May of 2017 for the Company's Vishakhapatnam facility.
Divi's Laboratories has filed a detailed responses and given updates to the Form-483 and the warning letter within the stipulated time. Divi's Laboratories, along with its external consultants, specialists and subject matter experts, has taken up appropriate remediation measures to address the concerns raised by USFDA. The company awaits further action from USFDA in this regard.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content